Healthcare - Medical - Devices - NASDAQ - US
$ 1.04
-3.7 %
$ 44.8 M
Market Cap
-1.01
P/E
BALANCE SHEET
143 M
ASSETS
25.5 M
LIABILITIES
118 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Rapid Micro Biosystems, Inc.
| Current Assets | 120 M |
| Cash & Short-Term Investments | 92.1 M |
| Receivables | 5.58 M |
| Other Current Assets | 22.8 M |
| Non-Current Assets | 23 M |
| Long-Term Investments | 2.91 M |
| PP&E | 19.1 M |
| Other Non-Current Assets | 1.05 M |
| Current Liabilities | 19 M |
| Accounts Payable | 1.97 M |
| Short-Term Debt | 2.26 M |
| Other Current Liabilities | 14.7 M |
| Non-Current Liabilities | 6.48 M |
| Long-Term Debt | 12.4 M |
| Other Non-Current Liabilities | -5.95 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 24.3 | 27.1 | 178.4 | 30.1 | 12.5 |
| Short Term Investments | 67.8 | 81.6 | 15.1 | 15.0 | 0.1 |
| Receivables | 5.6 | 5.5 | 5.4 | 5.8 | 4.9 |
| Inventory | 20.0 | 21.2 | 15.7 | 9.0 | 5.8 |
| Other Current Assets | 2.8 | 3.3 | 3.6 | 2.3 | 0.5 |
| Total Current Assets | 120.4 | 138.6 | 218.1 | 62.1 | 23.6 |
| PP&E | 19.1 | 20.9 | 11.3 | 7.1 | 7.6 |
| Intangible Assets | 0 | 1.4 | 1.3 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 2.9 | 29.8 | 10.0 | 100 K | 0.2 |
| Other Long Term Assets | 1.1 | 1.4 | 1.8 | 0.7 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 143.5 | 190.7 | 241.2 | 70.0 | 31.7 |
| LIABILITIES | |||||
| Accounts Payable | 2.0 | 5.4 | 3.9 | 4.5 | 3.2 |
| Short Term Debt | 2.3 | 1.5 | 0 | 0 | 0 |
| Other Current Liabilities | 8.5 | 7.1 | 10.1 | 6.0 | 4.8 |
| Total Current Liabilities | 19.0 | 19.1 | 18.2 | 15.5 | 10.5 |
| Long Term Debt | 12.4 | 14.4 | 0 | 24.8 | 17.8 |
| Deferred Tax Income | 0 | 0 | 0 | (0.7) | (0.7) |
| Other Liabilities | (6.0) | (7.0) | 2.0 | 4.8 | 4.1 |
| Total Liabilities | 25.5 | 26.5 | 20.2 | 45.2 | 32.4 |
| EQUITY | |||||
| Common Stock | 0.4 | 0.4 | 0.4 | 6 K | 4 K |
| Retained Earnings | (428.4) | (375.9) | (315.1) | (241.6) | (204.5) |
| Other Accumulative Comprehensive Income/Loss | (0.1) | (1.1) | 16 K | 1 K | 0 |
| Total Equity | 118.0 | 164.2 | 221.0 | 24.8 | (0.7) |
| Total Liabilities and Equity | 143.5 | 190.7 | 241.2 | 70.0 | 31.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 43.0 | 42.5 | 41.5 | 38.7 | 39.7 |